Journal of Lipid Research (Apr 2008)

Human apolipoprotein C-I expression in mice impairs learning and memory functions

  • Karlygash Abildayeva,
  • Jimmy F.P. Berbée,
  • Arjan Blokland,
  • Paula J. Jansen,
  • Frans J. Hoek,
  • Onno Meijer,
  • Dieter Lütjohann,
  • Thomas Gautier,
  • Thierry Pillot,
  • Jan De Vente,
  • Louis M. Havekes,
  • Frans C.S. Ramaekers,
  • Folkert Kuipers,
  • Patrick C.N. Rensen,
  • Monique Mulder

Journal volume & issue
Vol. 49, no. 4
pp. 856 – 869

Abstract

Read online

The H2 allele of APOC1, giving rise to increased gene expression of apolipoprotein C-I (apoC-I), is in genetic disequilibrium with the APOE4 allele and may provide a major risk factor for Alzheimer's disease (AD). We found that apoC-I protein is present in astrocytes and endothelial cells within hippocampal regions in both human control and AD brains. Interestingly, apoC-I colocalized with β-amyloid (Aβ) in plaques in AD brains, and in vitro experiments revealed that aggregation of Aβ was delayed in the presence of apoC-I. Moreover, apoC-I was found to exacerbate the soluble Aβ oligomer-induced neuronal death. To establish a potential role for apoC-I in cognitive functions, we used human (h) APOC1+/0 transgenic mice that express APOC1 mRNA throughout their brains and apoC-I protein in astrocytes and endothelial cells. The hAPOC1+/0 mice displayed impaired hippocampal-dependent learning and memory functions compared with their wild-type littermates, as judged from their performance in the object recognition task (P = 0.012) and in the Morris water maze task (P = 0.010). ApoC-I may affect learning as a result of its inhibitory properties toward apoE-dependent lipid metabolism. However, no differences in brain mRNA or protein levels of endogenous apoE were detected between transgenic and wild-type mice. In conclusion, human apoC-I expression impairs cognitive functions in mice independent of apoE expression, which supports the potential of a modulatory role for apoC-I during the development of AD.

Keywords